Vicenç Falcó

ORCID: 0000-0001-9626-0023
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • HIV Research and Treatment
  • Pneumocystis jirovecii pneumonia detection and treatment
  • HIV/AIDS drug development and treatment
  • Pneumonia and Respiratory Infections
  • HIV/AIDS Research and Interventions
  • Respiratory viral infections research
  • Immune Cell Function and Interaction
  • HIV-related health complications and treatments
  • COVID-19 Clinical Research Studies
  • Hepatitis C virus research
  • Colorectal and Anal Carcinomas
  • Cervical Cancer and HPV Research
  • Antibiotics Pharmacokinetics and Efficacy
  • Tuberculosis Research and Epidemiology
  • SARS-CoV-2 and COVID-19 Research
  • Viral-associated cancers and disorders
  • Antibiotic Resistance in Bacteria
  • Cytomegalovirus and herpesvirus research
  • Infectious Diseases and Tuberculosis
  • T-cell and B-cell Immunology
  • Hepatitis B Virus Studies
  • Liver Disease Diagnosis and Treatment
  • Bacterial Infections and Vaccines
  • Research on Leishmaniasis Studies
  • COVID-19 Impact on Reproduction

Universitat Autònoma de Barcelona
2016-2025

Vall d'Hebron Institut de Recerca
2016-2025

Vall d'Hebron Hospital Universitari
2013-2025

Botkin Hospital
2021

Hebron University
2009-2018

Office of Infectious Diseases
2008-2017

Instituto Maimónides de Investigación Biomédica de Córdoba
2017

Hospital Universitario Reina Sofía
2017

Universitat de Barcelona
2005-2013

Weatherford College
2011

Latency reversal agents (LRAs) have proven to induce HIV-1 transcription in vivo but are ineffective at decreasing the size of latent reservoir antiretroviral treated patients. The capacity LRAs perturb viral present distinct subpopulations cells is currently unknown. Here, using a new RNA FISH/flow ex reactivation assay, we performed comprehensive assessment different families LRAs, and their combinations, CD4+ T cell subsets. We observed that median 16.28% whole HIV-reservoir induced...

10.1371/journal.ppat.1007991 article EN cc-by PLoS Pathogens 2019-08-19

Abstract Resident memory T cells (T RM ) positioned within the respiratory tract are probably required to limit SARS-CoV-2 spread and COVID-19. Importantly, mostly non-recirculating, which reduces window of opportunity examine these in blood as they move lung parenchyma. Here, we identify circulating virus-specific cell responses during acute infection with functional, migratory apoptotic patterns modulated by viral proteins associated clinical outcome. Disease severity is predominantly IFNγ...

10.1038/s41467-021-23333-3 article EN cc-by Nature Communications 2021-05-21
Thomas M. File Donald E. Low Paul B. Eckburg George H. Talbot H. David Friedland and 95 more Jon Lee Lily Llorens Ian A. Critchley Dirk Thye John Pullman Philip Giordano James Welker Paul Manos P. Mehra Thomas M. File Joana Espírito Santo B. Venkateswaralu C. G. Schrock William Tillis Jan A. Winetz Javier González Andrew G. Ramage Dwight D. Eisenhower Coenraad F.N. Koegelenberg Ingrid Engelbrecht Julie A. Jurgens Ismail Mitha J. Breedt Mashra Gani Jack Roos Marc D. Basson Louis van Zyl Ronel Meeding Muhammed Ameen Fulat M. Le Roux Pablo Bonvehí María Cristina Ganaha A. L. Gurini Gustavo Lopardo Laura Cristina Sergio Prieto Celestino Rodíguez Ricardo Teijeiro E Pallone Daniel Pryluka Clóvis Arns da Cunha N. B. da Silva António Freire Cláudia Starling J. Costa Fiterman Fernando Gôngora Rubio L. Carlos Losso Marco Patelli J. Souza Lima Paulo José Zimermann Teixeira Marta Moreira J. C. Abreu de Oliveira V. Roudas E. A. Gamal I. V. Leschenko В. А. Руднов A. G. Yevdokimova A. L. Vertkin Y. M. Ambalov I. V. Dvoryashina E. Zilber R. F. Khamitov A. N. Galustyan O. V. Reshetko Victoria Senior M. F. Grosan Gabriela Jimborean M. Lupse G. Aron Dan Olteanu Maria Puşchiţă Claudia Gavriș V. M. Tudorache Vania Youroukova M Petkova E. Troshanova M. Dzhabalyan G Kavtaradze M. Makhviladze R. Tabukashvili Marco Pons Jorge Garbino Daniel Genné Madeleine Rothen J. O. de Saracho A. Capelastegui Rosario Menéndez Antoní Torres C. Shum Vicenç Falcó Emilio Bouza J.P. Bru Benoît Misset Bruno Mégarbane J.-P. Sollet

Ceftaroline, the active form of prodrug ceftaroline fosamil, is a novel cephalosporin with bactericidal activity against important pathogens associated community-acquired pneumonia (CAP), including Streptococcus pneumoniae and common Gram-negative pathogens. FOCUS 1 randomized, double-blinded, Phase III study that was conducted to evaluate efficacy safety fosamil in treating patients CAP. The primary objective determine non-inferiority [lower limit 95% confidence interval (CI) ≥ −10%]...

10.1093/jac/dkr096 article EN Journal of Antimicrobial Chemotherapy 2011-04-01

Lactic acidosis is a rare but often fatal complication reported in some human immunodeficiency virus (HIV)-infected patients treated with nucleoside-analogue reverse-transcriptase inhibitors. We report series of 12 HIV infection nucleoside analogues who developed unexplained metabolic acidosis. have also reviewed 60 additional published cases. The aim the present study to describe clinical picture, prognostic factors, and final outcome for nucleoside-associated lactic mortality rate high:...

10.1086/339041 article EN Clinical Infectious Diseases 2002-03-15
Catherine Orrell Debbie Hagins Elena Belonosova Norma Porteiro Sharon Walmsley and 95 more Vicenç Falcó Choy Man Alicia Aylott Ann M. Buchanan Brian Wynne Cindy Vavro Michael Aboud Kimberly Y. Smith Pedro Cahn Lidia Isabel Cassetti Norma Porteiro Barreira Jonathan B. Angel Alexandra de Pokomandy Marianne Harris Anita Rachlis Sharon Walmsley Clotilde Allavena Oliver Bouchaud Caroline Gatey Agathe Rami Salvatore Casari Giovanni Di Perri Adriano Lazzarin Franco Maggiolo Giovanni Penco Tiziana Quirino Giuliano Rizzardini Jaime Andrade‐Villanueva Juan Sierra‐Madero Teresa Branco Rosário Serrão Eugénio Teófilo Ivan Melendez-Rivera Lizette Santiago Carmen Zorrilla Elena Belonosova Oksana Chernova Vadim Pokrovsky Aza Rakhmanova Olga Aleksandrovna Tsybakova Eugene Voronin Catherine Orrell Tasneem Vally Livhuwani ML. Farisani Boitumelo Lucrecia Sebopa Carlos Aguado Barros Alfredo Cano Sánchez Manuel Castaño Vicens Falcó Ferrer Juan González‐García José Hernández‐Quero Eugènia Negredo Marı́a Jesús Pérez-Elı́as Daniel Podzamczer Palter Joaquín Portilla Pompeyo Viciana Fernández Weerawat Manosuthi Kiat Ruxrungtham David H. Dockrell Phillip Hay Margaret Johnson Nicola Mackie Chloe Orkin Stephen Taylor Laveeza Bhatti Indira Brar Robert Owen Brennan Jerry Cade Beata Casańas Kathleen Casey Douglas Cunningham Edwin DeJesus Craig Dietz Robin Dretler Joseph J. Eron Franco Antoni B. Felizarta Kenneth H. Fife Debbie Hagins Margaret Hoffman-Terry Mamta K. Jain Marc Alexander Johnson Clifford A. Kinder Princy Kumar Stanley T. Lewis Cheryl McDonald Armando Meza Karam Mounzer Cheryl Newman Olayemi Osiyemi Ronald Poblete Rachel M. Presti Moti Ramgopal Joel Rosenstock Rafik Samuel Uriel Sandkovsky

10.1016/s2352-3018(17)30095-4 article EN The Lancet HIV 2017-07-18

Cells that actively transcribe HIV-1 have been defined as the "active viral reservoir" in HIV-infected individuals. However, important technical limitations precluded characterization of this specific reservoir during both treated and untreated infections. Here, we used a novel single-cell RNA fluorescence situ hybridization-flow cytometry (FISH-flow) assay requires only 15 million unfractionated peripheral blood mononuclear cells (PBMCs) to characterize cell subpopulations HIV different...

10.1128/mbio.00876-17 article EN cc-by mBio 2017-07-12

Abstract HIV viral reservoirs are established very early during infection. Resident memory T cells (T RM ) present in tissues such as the lower female genital tract, but contribution of this subset to pathogenesis and persistence remains unclear. Here, we show that cervical CD4 + display a unique repertoire clusters differentiation, with enrichment several molecules associated infection susceptibility, longevity self-renewing capacities. These protein profiles enriched fraction expressing...

10.1038/s41467-019-12732-2 article EN cc-by Nature Communications 2019-10-18
Federico Pulido Esteban Ribera María Lagarde Ignacio Valero Rosario Palacios and 95 more José Antonio Iribarren Antoni Payeras Peré Domingo José Sanz Miguel Cervero Adrián Curran Francisco Javier Rodríguez‐Gómez María Jesús Téllez Pablo Ryan Pilar Barrufet Hernando Knobel Antonio Rivero Belén Alejos María Yllescas José Ramón Arribas José Ramón Arribas Rocío Montejano Juan González‐García Marisa Montes José Ignacio Bernardino Ignacio Valero Juan Castro Mario Mayoral Federico Pulido María Lagarde Otilia Bisbal Mariano Matarranz Asunción Hernando Lourdes Domínguez Rafael Rubio Esteban Ribera Adrián Curran Jordi Navarro Joaquín Burgos I Ocaña Vicenç Falcó José Ramón Santos Rosario Palacios Ignacio Pérez Carmen María González-Domenech Maialen Ibarguren Miguel Ángel Goenaga Francisco Rodríguez-Arrondo M. A. von Wichmann Xabier Kortajarena M.P. Carmona H Son Llatzer Antoni Payeras Maison Abu Raya Andrea Salom Peré Domingo María Luisa Navarro Gómez M. Gracia Mateo M. A. Sambeat José Sanz J. de Miguel E Casas Alberto Arranz Miguel Cervero Rafael Torres H Infanta Elena Francisco Javier Rodríguez‐Gómez J M Fajardó Francisco Javier Martı́nez-Marcos María de la Paz Valverde Merino Miguel Raffo Ignacio Suárez-Lozano H. Clínico María Jesús Téllez Jorge Vergas Vicente Estrada H Infanta Leonor Pablo Ryan Jesús Troya Guillermo Cuevas Victorino Diez-Viñas Tamar Talaván F Solís H de Mataró Pilar Barrufet Lluís Force Hanna Mar Hernando Knobel A. M. Maceira Gonzalez Edgar V. Lerma J. Villar H Reina Sofía Antonio Rivero Ángela Camacho Isabel Machuca Teresa Brieva António Rivero‐Juarez JM Gatell R. Domínguez Daniel Podzamczer

Our objective was to assess the therapeutic noninferiority of dual therapy with darunavir/ritonavir and lamivudine compared triple plus 2 nucleos(t)ides for maintenance human immunodeficiency virus type 1 (HIV-1) suppression.This a multicenter, open-label, trial (margin 12%). Patients HIV-1 RNA <50 copies/mL 6 months or longer on (tenofovir disoproxil fumarate emtricitabine abacavir lamivudine) no resistance were randomized continue (n = 128) switch 129). The primary endpoint proportion...

10.1093/cid/cix734 article EN Clinical Infectious Diseases 2017-08-12
Daniel K. Nomah Juliana Reyes‐Urueña Yesika Díaz Sergio Moreno‐Fornés Jordi Aceitón and 95 more Andreu Bruguera Rosa Maria Vivanco‐Hidalgo Josep M. Llibre Peré Domingo Vicenç Falcó Arkaitz Imaz Cristina Cortés Lluís Force Emili Letang Ingrid Vilaró Jordi Casabona José M Miró Esteve Muntada Anna Esteve Melchor Riera Gemma Navarro Hernando Knobel Josep Mallolas Daniel Podzamczer Adrián Curran Joaquín Burgos María Gracia Mateo María del Mar Gutiérrez Javier Murillas Francisco Homar José Vicente Fernández-Montero Eva López González Joaquim Peraire Francesc Vidal Elena León Àngels Masabeu Amat-Joaquim Orti David Dalmau Ángeles Jaén Elisabet Deig Elisa de Lazzari Leire Berrocal Guillem Fernandez Lucía Rodríguez‐Vázquez Freya Gargoulas Toni Vanrell Jose Carlos Rubia Josep Vilà Marina Martínez Bibiana Morell Maribel Tamayo Jorge Palacio Juan Ambrosioni Montse Laguno Marı́a Martı́nez-Rebollar José Luís Blanco Felipe García Estebán Martínez Berta Torres Lorena de la Mora Alexy Inciarte Ainoa Ugarte Iván Chivite Ana González-Cordón Lorna Leal Antoni Jou María Saumoy Ana Silva Sofía Scévola Jordi Navarro Paula Suanzes Isabel Mur Maria Àngels Ribas Antoni A Campins Francisco Fanjul María Leyes María Luz Pintos Peñaranda Marisa Martín Helem Vílchez Sònia Calzado Manel Cervantes María José Amengual Marta Navarro Antoni Payeras Carmen Luna Aroa Villoslada Gelabert Patrícia Sorní Marta Molero Nadia Abdulghani Thaïs Comella Rocio Sola Montserrat Vargas Consuleo Viladés Anna Martí Pilar Barrufet Laia Arbonés Elena Chamarro Mireia Cairó Xavier Martinez-Lacas Roser Font

BackgroundFactors affecting outcomes of SARS-CoV-2 infection in people living with HIV are unclear. We assessed the factors associated diagnosis and severe among HIV.MethodsWe did a retrospective cohort study using data from PISCIS Catalonia (Spain) between March 1 Dec 15, 2020. linked integrated health-care, clinical, surveillance registries through Public Data Analysis for Health Research Innovation Program (PADRIS) to obtain on diagnosis, chronic comorbidities, as well clinical mortality...

10.1016/s2352-3018(21)00240-x article EN other-oa The Lancet HIV 2021-10-15

We studied all human immunodeficiency virus (HIV)-infected patients with invasive pneumococcal disease who received their diagnosis during 1996-2002 to investigate the incidence of this in highly active antiretroviral therapy era and study influence CD4 lymphocyte count on clinical presentation outcome disease. The overall was 11.3 cases per 100,000 person-years adult without known HIV infection 677 HIV-infected patients. This remained stable over period. Clinical presentation, severity...

10.1086/420933 article EN Clinical Infectious Diseases 2004-05-18

To determine whether rifampicin reduces serum concentrations of nevirapine and modifies rifampicin, levels these agents were determined at steady state by high-performance liquid chromatography in 10 HIV-infected patients with tuberculosis. The median area under the curve (AUC) 0-12h before after was 56.2 32.8 microg/ml per hour, respectively ( p =.04). This represents a 31% reduction concentrations. C(max) decreased from 5.6 to 4.5 =.04), which represented 36% reduction. A 21% decrease...

10.1097/00042560-200112150-00007 article EN JAIDS Journal of Acquired Immune Deficiency Syndromes 2001-12-01

The role of pneumococcal urinary antigen detection in the treatment adults with community-acquired pneumonia (CAP) is not well defined. We assessed usefulness diagnosis and antimicrobial guidance patients hospitalized CAP.A prospective study all CAP was performed from February 2007 through January 2008. To evaluate accuracy test, we calculated its sensitivity, specificity, positive negative predictive values, likelihood ratios. gold standard used for isolation blood or pleural fluid...

10.1001/archinternmed.2010.347 article EN Archives of Internal Medicine 2010-09-28

Human immunodeficiency virus (HIV) infection induces immunological dysfunction, which limits the elimination of HIV-infected cells during treated infection. Identifying and targeting dysfunctional immune might help accelerate purging persistent viral reservoir. Here, we show that chronic HIV increases natural killer (NK) cell populations expressing negative regulator KLRG1, both in peripheral blood lymph nodes. Antiretroviral treatment (ART) does not reestablish these functionally impaired...

10.1016/j.xcrm.2023.101202 article EN cc-by-nc-nd Cell Reports Medicine 2023-09-22

Abstract Resident memory T cells (T RM ) present at the respiratory tract may be essential to enhance early SARS-CoV-2 viral clearance, thus limiting infection and disease. While long-term antigen-specific are detectable beyond 11 months in lung of convalescent COVID-19 patients, it is unknown if mRNA vaccination encoding for S-protein can induce this frontline protection. Here we show that frequency CD4 + secreting IFNγ response S-peptides variable but overall similar mRNA-vaccinated...

10.1038/s41467-023-37559-w article EN cc-by Nature Communications 2023-04-05

Background: The aim of this study was to analyze the incidence new cases, survival HIV-1-infected patients with progressive multifocal leukoencephalopathy (PML), and characteristics PML-associated immune reconstitution inflammatory syndrome (IRIS). Methods: Multicenter observational cohort all newly diagnosed PML in 7 hospitals Barcelona (Spain) from 2002 2006. annual calculated. Survival estimated using Kaplan-Meier method. IRIS defined as onset or rapid worsening shortly after initiation...

10.1097/qai.0b013e31817bec64 article EN JAIDS Journal of Acquired Immune Deficiency Syndromes 2008-08-22

Background. Increased rates of empyema have been reported in children after the introduction pneumococcal conjugate vaccine (PCV7). Our objective was to describe risk factors for adults and analyze differences incidence, disease characteristics, serotype distribution between pre- post-PCV7 eras.

10.1093/cid/cir354 article EN Clinical Infectious Diseases 2011-07-15

Abstract The identification of exclusive markers to target HIV-reservoir cells will represent a significant advance in the search for therapies cure HIV. Here, we identify B lymphocyte antigen CD20 as marker HIV-infected vitro and vivo. molecule is dimly expressed subpopulation CD4-positive (CD4 + ) T lymphocytes from blood, with high levels cell activation heterogeneous memory phenotypes. In lymph node samples infected patients, present productively cells, ex vivo viral infection...

10.1038/s41467-019-11556-4 article EN cc-by Nature Communications 2019-08-16

The development of physiological models that reproduce SARS-CoV-2 infection in primary human cells will be instrumental to identify host-pathogen interactions and potential therapeutics. Here, using cell suspensions directly from lung tissues (HLT), we have developed a rapid platform for the identification viral targets expression entry factors, as well screening inhibitors anti-inflammatory compounds. direct use HLT cells, without long-term culture vitro differentiation approaches,...

10.1371/journal.ppat.1010171 article EN cc-by PLoS Pathogens 2022-01-13

Vaccines against smallpox are known to have cross-protective activity monkeypox, and monkeypox infections believed generate permanent immunity. Nevertheless, there scarce data about the possibility of reinfection or reactivation. Recently, a case apparent has been reported. We present suspected second episode in healthy previously vaccinated man, with confirmed primary infection occurring three months before presentation.

10.1177/09564624231162426 article EN International Journal of STD & AIDS 2023-04-26

Background: Lipoatrophy is the most stigmatizing side effect of stavudine therapy. We assessed long-term effects replacing with tenofovir in HIV-infected patients lipoatrophy. Method: Prospective switch study. Sixty-two clinically stable antiretroviral therapy (ART) containing stavudine, HIV-1 RNA <50 copies/mL, and lipoatrophy at least face on physical examination were included. All switched from to without changing any other drug. Objective (malar ultasonography, bioelectrical impedance...

10.1310/hct0906-407 article EN HIV Clinical Trials 2008-12-01

Latent parasitic infections can reactivate because of immunosuppression. We conducted a prospective observational study all human immunodeficiency virus (HIV)–infected immigrants who visited the Infectious Diseases Department Hospital Universitari Vall d'Hebron, Barcelona, Spain, during June 2010–May 2011. Screening most prevalent tropical diseases (intestinal parasitosis, Chagas disease, leishmaniasis, malaria, schistosomiasis, and strongyloidiasis) was performed according to geographic...

10.4269/ajtmh.12-0714 article EN American Journal of Tropical Medicine and Hygiene 2013-03-19
Coming Soon ...